| K-number | K250588 |
| Device name | Access Rubella IgG |
| Applicant | Beckman Coulter, Inc. |
| Product code | LFX |
| Device class | Class II |
| Decision date | Nov 17, 2025 |
| Decision | Substantially Equivalent |
| Regulation | 866.3510 |
The FDA summary PDF for this submission is not available in machine-readable form — common for older clearances. View on FDA's site →
View the full FDA submission: accessdata.fda.gov